A Possible Role of Serum Soluble TNF-related Apoptosis-Inducing Ligand (TRAIL) in Pathogenesis of Systemic Lupus Erythematosus

Dysregulation of Tumor Necrosis Factor Alpha-Induced Protein 3 mRNA Expression in Lupus Nephritis in Relation to Clinic-pathologic Characteristics and Disease Activity of Systemi

Serum levels of soluble CD95 in patients with systemic lupus erythematosus

Interleukin-22 and Tumor Necrosis Factor Receptor Associated Factor 1 (TRAF1) in Patients with Rheumatoid Arthritis and Systemic Lupus Erythematosus: Correlation with Disease Activity

T Helper 17 Cells and Inducible Nitric Oxide Synthase: Good Index to Predict Renal Tissue Involvement in Systemic Lupus Erythematosus Patients

T FOLLICULAR REGULATORY CELL (TFR) IN SYSTEMIC LUPUS ERYTHEMATOSUS AND ITS RELATION TO DISEASE ACTIVITY

Possible involvement of IL-18 in SLE-dysregulated apoptosis and cytopenia

Serum Neopterin Level in Systemic Lupus Erythematosus: Relation toDisease Activity, Organ Affection and Different Therapy Regimens

TOLL-LIKE RECEPTORS 4 AND 9 EXPRESSION IN SYSTEMIC LUPUS ERYTHEMATOSUS AND DERMATOMYOSITIS: RELATION TO CLINICAL STATUS AND DISEASE ACTIVITY

T-cell markers in systemic lupus erythromatosus patients